CFP: SSRI, Depression, Phenomenology

Call for Papers

SSRI, Depression, Phenomenology

Psychiatria Danubina, ISSN 0353-5053

Over the past two decades the reception of selective serotonin reuptake inhibitors has shifted. Early phenomenological work approached the drugs with cautious openness (Svenaeus, 2006). Later empirical phenomenological studies documented a more troubled picture of emotional flattening and disconnection (Teal, 2009). This shift runs parallel to the collapse of the serotonin hypothesis of depression in psychiatric research (Moncrieff et al., 2022). This issue invites short contributions examining this changing reception across philosophy, history, and clinical psychiatry.

Topics

- phenomenology and philosophy of depression and SSRIs

- historical analysis of SSRI reception since the 1990s

- critical reviews of the serotonin hypothesis

- clinical and psychiatric perspectives on SSRI efficacy

- bioethics and informed consent in antidepressant prescribing

- discontinuation and withdrawal research

- sociological and cultural analysis of antidepressant use

- gender and embodiment in depression and treatment

- patient narratives and qualitative studies of SSRI experience

- comparative approaches combining biochemical and phenomenological critique

Requirements

- length minimum 2 pages, maximum 20 pages, ideal length around 5 pages

- language English - citation style APA

- original, unpublished work

Submission

Send manuscripts to [email protected] by 25 August 2026.

Publication Accepted texts will appear in the September 2026 issue of Psychiatria Danubina.